Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Capital Expenditures (2016 - 2026)

Amphastar Pharmaceuticals has reported Capital Expenditures over the past 13 years, most recently at $1.2 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 90.23% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $7.7 million, down 81.14%, while the annual FY2025 figure was $7.7 million, 81.14% down from the prior year.
  • Capital Expenditures for Q4 2025 was $1.2 million at Amphastar Pharmaceuticals, up from $474000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $33.7 million in Q4 2023 and troughed at -$11.1 million in Q4 2021.
  • A 5-year average of $6.0 million and a median of $6.1 million in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: plummeted 220.1% in 2022 and later skyrocketed 1592.39% in 2024.
  • Year by year, Capital Expenditures stood at -$11.1 million in 2021, then soared by 285.78% to $20.6 million in 2022, then surged by 63.42% to $33.7 million in 2023, then crashed by 63.14% to $12.4 million in 2024, then tumbled by 90.23% to $1.2 million in 2025.
  • Business Quant data shows Capital Expenditures for AMPH at $1.2 million in Q4 2025, $474000.0 in Q3 2025, and -$4.6 million in Q2 2025.